Work

BMS-986278, a lysophosphatidic acid 1 (LPA1) receptor antagonist, in healthy participants: A single/multiple ascending dose (SAD/MAD) phase 1 study

Year: 2019

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2019.pa1398

Authors: Giridhar Tirucherai, Dale Yu, Ratna Revankar, George Klinger, Jan Jaap Van Lier, Jorg Taubel, Todd Correll

Institutions: Bristol-Myers Squibb (United States), PRA Health Sciences, St George's, University of London

Language: English

Topic: Sphingolipid Metabolism and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2990445664

Cites:

Cited by: 6

Related to: 10